CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | -38.5% | 13,950 | -3.3% | 0.01% | -33.3% |
| Q2 2022 | $26,000 | -10.3% | 14,424 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $29,000 | -29.3% | 14,424 | -4.5% | 0.01% | -25.0% |
| Q4 2021 | $41,000 | -42.3% | 15,099 | -4.7% | 0.02% | -51.5% |
| Q3 2021 | $71,000 | -22.8% | 15,849 | 0.0% | 0.03% | -21.4% |
| Q2 2021 | $92,000 | -17.1% | 15,849 | 0.0% | 0.04% | -48.1% |
| Q1 2021 | $111,000 | +46.1% | 15,849 | 0.0% | 0.08% | +97.6% |
| Q4 2020 | $76,000 | – | 15,849 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |